10 | CytokinesIBA
12/2023
-
05/2012 |
7 | LigandsIBA
01/2023
-
02/2007 |
7 | Antiviral Agents (Antivirals)IBA
01/2022
-
10/2012 |
5 | Proteins (Proteins, Gene)FDA Link
12/2023
-
10/2011 |
4 | Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2023
-
01/2018 |
4 | AntigensIBA
12/2023
-
10/2015 |
3 | Biomarkers (Surrogate Marker)IBA
01/2024
-
01/2020 |
3 | Hepatitis B e AntigensIBA
12/2023
-
01/2018 |
3 | RNA (Ribonucleic Acid)IBA
01/2022
-
05/2010 |
3 | InterferonsIBA
01/2016
-
05/2012 |
2 | ProteomeIBA
02/2023
-
01/2022 |
2 | Blood Proteins (Serum Proteins)IBA
02/2023
-
01/2023 |
2 | Interleukin-6 (Interleukin 6)IBA
01/2023
-
10/2019 |
2 | Membrane Proteins (Integral Membrane Proteins)IBA
01/2023
-
01/2022 |
2 | AntibodiesIBA
01/2021
-
06/2013 |
2 | alpha-Fetoproteins (alpha-Fetoprotein)IBA
12/2020
-
09/2009 |
2 | HLA Antigens (Human Leukocyte Antigens)IBA
10/2019
-
02/2007 |
2 | DNA (Deoxyribonucleic Acid)IBA
01/2018
-
01/2018 |
2 | KIR ReceptorsIBA
10/2012
-
02/2012 |
2 | CD226 antigenIBA
05/2012
-
02/2007 |
2 | Natural Killer Cell ReceptorsIBA
05/2012
-
02/2010 |
2 | Ribavirin (Virazole)FDA LinkGeneric
05/2010
-
11/2009 |
1 | Interferon Type IIBA
02/2024 |
1 | AutoantibodiesIBA
02/2024 |
1 | CeramidesIBA
01/2023 |
1 | Complement System Proteins (Complement)IBA
01/2023 |
1 | sofosbuvir drug combination ledipasvirIBA
01/2022 |
1 | Messenger RNA (mRNA)IBA
01/2022 |
1 | XenobioticsIBA
01/2022 |
1 | Dihydrotachysterol (AT 10)IBA
01/2022 |
1 | 2,6-dinitrotoluene (DNT)IBA
01/2022 |
1 | 3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA
01/2021 |
1 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2020 |
1 | ChemokinesIBA
10/2020 |
1 | Small Cytoplasmic RNAIBA
01/2020 |
1 | HLA-DR Antigens (HLA-DR)IBA
01/2020 |
1 | Immunoglobulins (Immunoglobulin)IBA
10/2019 |
1 | AlbuminsIBA
01/2019 |
1 | Interleukin-18 (Interleukin 18)IBA
01/2019 |
1 | N-acetyltalosaminuronic acid (NAT)IBA
07/2018 |
1 | Surface Antigens (Surface Antigen)IBA
01/2018 |
1 | Peptides (Polypeptides)IBA
01/2018 |
1 | Imatinib Mesylate (Gleevec)FDA Link
02/2016 |
1 | Sorafenib (BAY 43-9006)FDA Link
02/2016 |
1 | Platelet-Derived Growth FactorIBA
02/2016 |
1 | Sunitinib (Sutent)FDA Link
02/2016 |
1 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2016 |
1 | 1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
01/2016 |
1 | VaccinesIBA
01/2016 |
1 | Immunoglobulin A (IgA)IBA
06/2013 |
1 | Therapeutic UsesIBA
05/2012 |
1 | Interleukin-2 (IL2)IBA
05/2012 |